期刊文献+

人β防御素3与植物巴西甜蛋白基因密码子的优化及其在毕氏酵母中的表达 被引量:2

Optimization mosaic gene of human β defensin 3 and plant des-pGlu1-Brazzein and its expression in Pichia pastoris
下载PDF
导出
摘要 根据人β防御素3和植物甜蛋白des-pGlu1-Brazzein的氨基酸序列,按照酵母密码子的偏爱性,合成了14段末端具有粘合位点的核苷酸序列,经连接、PCR扩增,使人β防御素3和植物甜蛋白des-pGlu1-Brazzein的编码序列通过1段序列(含凝血酶切割位点)连接成为嵌合基因,将其插入到pPIC9K载体中,构建重组表达载体pPIC9K-hBD3-Bra.SalⅠ,BglⅡ单酶切后,分别电击转化到毕赤酵母GS115中,构建野生型和乙醇氧化酶缺陷型酵母工程菌株GS115-pPIC9K-hBD3-Bra.筛选鉴定后,以体积分数为0.5%的甲醇进行诱导,缺陷型工程菌株表达的目的蛋白约占上清蛋白的90%,纯度较高,野生型工程菌株表达的目的蛋白约占上清蛋白的57.8%. According to the sequences of human β defensin 3 and plant sweet-tasting protein despGlul-Brazzein, fourteen pairs of oligoneucleotide with cosmid site were synthesized using yeasty biased codons. After linkage and PCR, the DNA sequence of human β defensin 3 and plant des-pGlu1- Brazzein were incorporated together with the sequences coding thrombin cleavage site between them. This recombinant gene sequence was inserted into pPIC9K which resulted in recombinant expression vector pPIC9K-hBD3-Bra. Linearized by Sal Ⅰ or Bgl Ⅱ ,the vectors were transformed into Pichia pastoris strain GS115 by electro shock to produce wild type and alcohol oxidase-defective expression strain respectively. Identified by G418 and PCR, the strain was induced by 0.5% methanol. The results showed that the target protein accounted for 57.8% and 90% of total protein in the supernatant for wild type and alcohol oxidase-defective strain respectively.
出处 《河南农业大学学报》 CAS CSCD 北大核心 2013年第1期77-82,共6页 Journal of Henan Agricultural University
基金 教育部科学技术研究重点项目(207069) 河南省自然科学基金项目(04110303000)
关键词 防御素 甜蛋白 基因合成 克隆表达 活性检测 defensin Brazzein gene synthesis recombinant expression activity analysis
  • 相关文献

参考文献3

二级参考文献29

  • 1陈姗,何凤田,董燕麟,李蓉芬,高会广,陈敏,彭家和.人β防御素3融合蛋白在大肠杆菌中的表达、纯化与活性分析[J].生物工程学报,2004,20(4):490-495. 被引量:20
  • 2Assadi-Porter F M, Aceti D J, Cheng H,et al. Efficient production of recombinant brazzein, a small, heat-stable, sweet-tasting protein of plant origin[ J]. Archives of Biochemistry and Biophysics, 2000, 376(2) :252-258.
  • 3Gao G H, Dao J X, Ding M, et al. Solution conformation of brazzein by ^1H nuclear magnetic resonance:resonance assignment and secondary structure [ J]. International Journal of Biological Macro- molecules, 1999,24 (4) : 351-359.
  • 4Hellekant G, Danilova V. Brazzein a small, sweet protein: discovery and physiological overview[ J]. Chemical Senses,2005,30(1): 88-89.
  • 5Hancock Robert E W. Cationic peptides: effectors in innate immunityand novel antimicrobials. Lancet Infect Dis, 2001,11( 1 ): 156 ~ 164.
  • 6Periathamby A R, Andrew R D. Current status of defensins and their role in innate and adaptive immunity. FEMS Microbiol Lett, 2002, 206: 9~ 18.
  • 7Ganz T, Selsted M E, Szklarek D, Harwig S S, Daher K, Bainton D F, Lehrer R I. Defensins, Natural peptide antibiotics of human neutrophils. J Clin Invest, 1985,76(4): 1427 ~ 1435.
  • 8Bensch K W, Raida M, Magert H J. hBD-1 :a novel beta-defensin from human plasma. FEBS Lett, 1995,368: 331.
  • 9Harder J, Bartels J. Christophers E, Schroder J M. A peptide antibiotic from human skin. Nature, 1997,387: 861.
  • 10Harder J, Bartels J. Christophers E, Schroder J M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem, 2001, 276(8): 5707~5713.

共引文献18

同被引文献31

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部